SEVEN EIGHT CAPITAL, LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$80,792
-47.8%
10,398
-34.9%
0.01%
-65.4%
Q2 2023$154,715
+15.5%
15,983
-10.6%
0.03%
-3.7%
Q3 2022$134,000
-62.4%
17,881
-49.5%
0.03%
-81.1%
Q2 2022$356,000
-74.6%
35,408
-68.7%
0.14%
-23.5%
Q1 2022$1,403,000
-78.1%
113,303
-60.8%
0.19%
-69.6%
Q3 2021$6,392,000
+994.5%
288,840
+540.7%
0.62%
+651.2%
Q2 2021$584,000
+8.8%
45,080
+23.7%
0.08%
-29.3%
Q3 2020$537,000
+52.1%
36,434
+49.9%
0.12%
+27.5%
Q1 2020$353,00024,3000.09%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders